Dynamics of Early Serum Tumour Markers and Neutrophil-to-Lymphocyte Ratio Predict Response to PD-1/PD-L1 Inhibitors in Advanced Non-Small-Cell Lung Cancer

PURPOSE: To evaluate the dynamics of early serum tumour markers (STMs) and the neutrophil-to-lymphocyte ratio (NLR) to predict clinical efficacy and prognosis of advanced non-small-cell lung cancer (NSCLC) patients who received programmed cell death-1 (PD-1)/programmed cell death-ligand 1 (PD-L1) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Yin, Cui, Yu, Li, Lin-lin, Guan, Ya-ping, Feng, Dong-feng, Yin, Bei-bei, Liang, Xue-feng, Yin, Jing, Jiang, Rui, Liang, Jing, Sun, Ya-hong, Wang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572022/
https://www.ncbi.nlm.nih.gov/pubmed/34754244
http://dx.doi.org/10.2147/CMAR.S329963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572022/
https://www.ncbi.nlm.nih.gov/pubmed/34754244
http://dx.doi.org/10.2147/CMAR.S329963

Ejemplares similares